Abstract: This invention is directed to a novel method and composition for the treatment of diabetes mellitus (Type I, Impaired Glucose Tolerance [“IGT”] and Type II). More specifically, this invention pertains to a novel method of treating diabetes mellitus by incorporating a therapeutic amount of one or more insulin sensitizers along with one or more of an orally ingested insulin, an injected insulin, a sulfonylurea, a biguanide or an alpha-glucosidase inhibitor for the treatment of diabetes mellitus.

Abstract: This invention is directed to a novel method and composition for the treatment of diabetes mellitus (Type I, Impaired Glucose Tolerance ["IGT"]and Type II). More specifically, this invention pertains to a novel method of treating diabetes mellitus by incorporating a therapeutic amount of one or more insulin sensitizers along with one or more of an orally ingested insulin, an injected insulin, a sulfonylurea, a biguanide or an alpha-glucosidase inhibitor for the treatment of diabetes mellitus.

Abstract: This invention is directed to a novel effervescing foaming bath shape or solid composition. More particularly, this invention pertains to a novel effervescing or foaming bath ball composition which has rapid mixing and production time, and antiseptic and skin conditioning properties. A bath shape or sold formulation comprising: (a) between 40 to 90% by weight of sodium bicarbonate; (b) between 5 to 50% by weight of organic acid; and (c) between 0.5 to 15% weight of alcohol. The formulation can also include (d) between 0.5 to 10% of vegetable oil; (e) between about 0.01 to 0.1 % weight of FD&C certified color to provide a pleasing color to the formulation; (f) between about 0.01 to 10% weight of fragrance to provide an appealing aroma to the composition, and a surfactant.